Guidelines for the programmatic management of drug-resistant tuberculosis.
Contributors: Rich, Michael.; World Health Organization.
Publisher: World Health Organization
Published: 2006
Place of publication: Geneva
Language: eng
Number of pages: 174
Subjects: Tuberculosis, Multidrug-Resistant -- drug therapy -- Practice Guideline; Antitubercular Agents -- Practice Guideline; HIV Infections -- drug therapy -- Practice Guideline; Tuberculosis, Multidrug-Resistant -- prevention & control -- Practice Guideline; Tuberculosis -- Chemotherapy; Tuberculosis -- Prevention; Antitubercular agents; HIV infections -- Chemotherapy
Genres: Practice Guideline.
Description: These new guidelines on the programmatic management of drug-resistant tuberculosis represent the best current knowledge in the management of drug-resistant TB and MDR-TB, and offer ample options to tailor diagnosis and care to different epidemiological and programmatic conditions worldwide. The recommendations, compiled by leading experts in the subject, should be followed without hesitation by all national programs and their partners as the most solid programmatic standards. At the same time, it is imperative to stress that the five elements of the DOTS strategy remain the cornerstone of TB control, and the most effective tool to prevent the onset and dissemination of drug resistance. Without the essential elements of TB control fully in place, management of MDR-TB will undoubtedly fail in the long term. These guidelines focus on care for MDR-TB patients, in the hope and expectation that, in future, the occurrence of massive numbers of cases can be prevented through sound TB control practices.--Publisher's description.
Notes: Editors-in-chief: Michael Rich ... [et al.]--P. iv.

"WHO/HTM/TB/2006.361".

Includes bibliographical references.

Also available in an electronic version.